GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioNxt Solutions Inc (XCNQ:BNXT) » Definitions » EBITDA Margin %

BioNxt Solutions (XCNQ:BNXT) EBITDA Margin % : -33,175.00% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioNxt Solutions EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. BioNxt Solutions's EBITDA for the three months ended in Mar. 2024 was C$-1.33 Mil. BioNxt Solutions's Revenue for the three months ended in Mar. 2024 was C$0.00 Mil. Therefore, BioNxt Solutions's EBITDA margin for the quarter that ended in Mar. 2024 was -33,175.00%.


BioNxt Solutions EBITDA Margin % Historical Data

The historical data trend for BioNxt Solutions's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNxt Solutions EBITDA Margin % Chart

BioNxt Solutions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial -3,203.37 -4,639.88 -6,710.84 -3,876.09 -1,743.28

BioNxt Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20,861.11 -706.47 -18,116.67 -10,780.00 -33,175.00

Competitive Comparison of BioNxt Solutions's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNxt Solutions's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's EBITDA Margin % falls into.



BioNxt Solutions EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

BioNxt Solutions's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-6.485/0.372
=-1,743.28 %

BioNxt Solutions's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-1.327/0.004
=-33,175.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNxt Solutions  (XCNQ:BNXT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


BioNxt Solutions EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of BioNxt Solutions's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNxt Solutions (XCNQ:BNXT) Business Description

Traded in Other Exchanges
Address
1820 Fir Street, Suite 270, Vancouver, BC, CAN, V6J 3B1
BioNxt Solutions Inc is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.

BioNxt Solutions (XCNQ:BNXT) Headlines

No Headlines